Cancer Case study

Psychosocial Assessment Mr. L. is a 69 year-old male with acute myelogenous leukemia (AML), FAB-M1 normal cytogenetics diagnosed in May of 2001. He received chemotherapy (7+3: AraC/idarubican) at that time and achieved complete remission. He developed a relapse in the April of 2002. He deferred treatment as he was trying alternative medicines. He eventually was treated with chemotherapy (Mylotarg) again in May of 2002, but this did not result in remission and he is considered to be in refractory …

…neutrophils may be caused by various bone marrow malignancies, such as chronic myelogenous leukemia. NEUT ABS 0.7 (2.4-7.56) ANC will often appear on the blood test report of a person receiving chemotherapy. It refers to the percentage of neutrophils (white blood cells that fight infection) and cells that will become neutrophils multiplied by the white blood count (WBC). MONO ABS 0.0 (0.05-0.60) Decreased monocyte levels can indicate bone marrow injury or failure and some forms of leukemia.